Johannes Jan
Johannes Jan Lukkien, Best NL
Patent application number | Description | Published |
---|---|---|
20130094493 | ESTABLISHING FAIRNESS AND REDUCING DELAY IN BROADCAST BASED VEHICLE TO VEHICLE COMMUNICATION USING APPLICATION-LEVEL PHASE ADJUSTMENTS - A method for a station to periodically broadcast messages over a wireless channel to communicate to multiple other stations who transmit on the same channel, the station becomes ready to broadcast at successive message activation times, at a message activation time the station performing a Multiple Access mechanism ( | 04-18-2013 |
Johannes Jan Platteeuw, Boxtel NL
Patent application number | Description | Published |
---|---|---|
20100183730 | High dose composition of ursodeoxycholic acid - The present invention relates to high dose multiparticulate pharmaceutical formulation comprising ursodeoxycholic acid for oral administration, as well as a method for preparing said composition. | 07-22-2010 |
20140235598 | TABLET CONTAINING DEHYDROEPIANDROSTERONE (DHEA) - The present invention relates to a tablet having a weight of 30-200 mg and consisting of: | 08-21-2014 |
20140235882 | PROCESS FOR THE PREPARATION OF ESTETROL - The present invention relates to a process for the preparation of estra-1,3,5(10)-trien-3,15α,16α,17β-tetraol (estetrol), via a silyl enol ether derivative 17-B-oxy-3-A-oxy-estra-1,3,5(10),16-tetraene, wherein A is a protecting group and B is —Si(R | 08-21-2014 |
Johannes Jan Platteeuw, Diegem BE
Patent application number | Description | Published |
---|---|---|
20150283108 | SULFESTROL FOR TREATING CANCER - The invention relates to the use of Sulfestrol (diethylstilbestrol sulfate) in a method of curative or palliative treatment of cancer in a mammal. The inventors have unexpectedly found that Sulfestrol can suitably be employed as an effective drug in the treatment of cancer in mammals. The inventors have further discovered that Sulfestrol can be administered even in high dosages without giving rise to serious side effects. Besides the clinical use of Sulfestrol the present invention also relates to oral dosage units comprising Sulfestrol and to sterile liquids for intravenous administration that comprise Sulfestrol. | 10-08-2015 |
20150283155 | FOSFESTROL FOR USE IN CURATIVE OR PALLIATIVE TREATMENT OF PROSTATE CANCER - The present invention relates to the use of Fosfestrol (diethylstilbestrol diphosphate) in a method of curative or palliative treatment of prostate cancer in male mammals, said method comprising orally administering Fosfestrol in a daily dosage of at least 1,000 mg. The inventors have discovered that Fosfestrol when administered in very high oral dosages is effective in the treatment of prostate cancer, especially hormone resistant prostate cancer, without giving rise to serious side effects, such as thromboembolic toxicity or mortality. The invention further provides an oral dosage unit comprising at least 500 mg, of Fosfestrol. | 10-08-2015 |